Glucagon-like peptide-1
Ein Hormon stellt sich vor: "Glucagon-like Peptide 1"
5
STUDY OF PALM OIL AND GLUTAMINE AS FUNCTIONAL FOODS ON PEPTIDE TYROSINE TYROSINE (PYY) AND GLUCAGON-LIKE PEPTIDE 1 (GLP-1) IN OBESE PATIENTS FOLLOWING UP ON THE AMBULATORY HEALTH SERVICES OF THE PUBLIC HOSPITAL
13
Clinical Application of Glucagon-Like Peptide 1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus
13
Mathematical Modeling of Interacting Glucose-Sensing Mechanisms and Electrical Activity Underlying Glucagon-Like Peptide 1 Secretion.
26
Glucagon-like peptide 1 improves insulin resistance in vitro through anti-in flammation of macrophages
9
Glucagon-like peptide-1 secretory function as an independent determinant of blood pressure: analysis in the Tanno-Sobetsu study.
8
The glucagon-like peptide 1 analogue Exendin-4 attenuates the nicotine-induced locomotor stimulation, accumbal dopamine release, conditioned place preference as well as the expression of locomotor sensitization in mice.
7
MIMéTICOS DO “GLUCAGON-LIKE PEPTIDE-1” (GLP-1) E O SEU POTENCIAL FARMACêUTICO NO CONTROLO DA DIABETES TIPO 2 E DA OBESIDADE
9
Albiglutide, a long lasting glucagon-like peptide-1 analog, protects the rat heart against ischemia/reperfusion injury: evidence for improving cardiac metabolic efficiency.
10
Glucagon-like peptide-1 receptor ligand interactions: structural cross talk between ligands and the extracellular domain.
9
Letter: Expression of Glucagon-Like Peptide-1 Receptor in Papillary Thyroid Carcinoma and Its Clinicopathologic Significance ( 2014;29:536-44, Min Jung Jung et al.)
2
Reversal of obesity and insulin resistance by a non-peptidic glucagon-like peptide-1 receptor agonist in diet-induced obese mice.
15
The Effect of Glucagon-Like Peptide 1 Receptor Agonists on Weight Loss in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison Meta-Analysis.
14
Expression of Glucagon-Like Peptide-1 Receptor in Papillary Thyroid Carcinoma and Its Clinicopathologic Significance
9
GLUCAGON-LIKE PEPTIDE 1: BIOChEMISTRy, SECRETION AND MAIN PhySIOLOGICAL EFFECTS
10
Beneficial Effects of Evogliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, on Adiposity with Increased Ppargc1a in White Adipose Tissue in Obese Mice.
19
Intestinal and Hepatic Niemann-Pick C1-Like 1
9
Influência do esvaziamento gástrico sobre o controle da glicemia pós-prandial: fisiologia e implicações terapêuticas.
3
Eficácia e Segurança dos Agonistas dos Recetores GLP-1 no Tratamento da Diabetes Mellitus Tipo 2: Revisão Sistemática
11
Einstein (São Paulo) vol.12 número2
3